Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR Public Health and Surveillance (no longer under consideration since Apr 23, 2025)

Date Submitted: Aug 19, 2024

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Beyond the Epidemic: Effective Public Health Strategies in Response to Nigeria's First Lassa Fever Outbreak in a Non-Endemic Region.

  • Samuel Terungwa Abaya; 
  • Dimie Ogoina; 
  • Jones Stow; 
  • Bio Belu Abaye; 
  • Chisom Emeka; 
  • Morufu Olalekan Raimi

ABSTRACT

Background:

Bayelsa State, located in Nigeria's Niger Delta region, had never reported a Lassa fever (LF) outbreak despite the country's 54-year history of such occurrences. This study examines the public health response components to the first-ever LF outbreak in Bayelsa State.

Objective:

To describe the public health strategies and challenges encountered during the management of Bayelsa State's first Lassa fever outbreak

Methods:

This descriptive observational study was conducted from February 8th to April 20th, 2023, employing both quantitative and qualitative methods. Sociodemographic, clinical, and public health data were collected from suspected and confirmed LF cases, including their contacts. Additionally, the study reviewed and documented the public health response plans, activities, and experiences during the outbreak

Results:

A total of 37 suspected cases were reported, with two confirmed positive via PCR. The index case was laboratory-confirmed approximately nine weeks after symptom onset and tragically passed away five days after her third hospital admission, just a day after diagnosis. The second case, a contact of the index, fully recovered following a mild illness. Among 95 identified contacts, 70 were categorized as high-risk, and 15 exhibited symptoms. All 20 contacts who were tested returned negative results. The outbreak was managed using a multidisciplinary One Health approach aligned with Nigeria’s LF emergency preparedness and response framework. One death was recorded, and 21 contacts were tested. Challenges included low suspicion among healthcare workers, inadequate infection control practices, insufficient personal protective equipment (PPE), shortages of medical commodities, and lack of funding.

Conclusions:

All communities within LF-endemic countries, regardless of prior outbreak status, must bolster their preparedness. Emphasis should be placed on preemptive sensitization and training of healthcare workers and investing in the sustainable availability of LF epidemic response commodities. Enhance preemptive healthcare worker sensitization and training in LF non-endemic regions, ensure sustainable availability of PPEs and other LF response commodities as well as strengthen infection control practices and outbreak response funding. This study highlights the importance of preparedness and rapid response, even in regions previously unaffected by LF outbreaks, to minimize the impact of emerging infectious diseases.


 Citation

Please cite as:

Abaya ST, Ogoina D, Stow J, Abaye BB, Emeka C, Raimi MO

Beyond the Epidemic: Effective Public Health Strategies in Response to Nigeria's First Lassa Fever Outbreak in a Non-Endemic Region.

JMIR Preprints. 19/08/2024:65539

DOI: 10.2196/preprints.65539

URL: https://preprints.jmir.org/preprint/65539

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.